METHOD OF TREATMENT OF PATIENTS WITH lingering pneumonia with use of the drug 'ruzam'

摘要

method u043bu0435u0447u0435u043du0438u00a0 patients with slow u0440u0430u0437u0440u0435u0448u0430u044eu0449u0435u0439u0441u00a0 (u0437u0430u0442u00a0u0436u043du043eu0439) pneumonia using u0440u0443u0437u0430u043cu0430, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 the clinical effect of the drug is not u043bu044cu043au043e with allergy, but also in other u0437u0430u0431u043eu043bu0435u0432u0430u043du0438u00a0u0445 - u0437u0430u0442u00a0u0436u043du044bu0445 u043fu043du0435u0432u043cu043eu043du0438u00a0u0445, u0440u0443u0437u0430u043c u0432u0432u043eu0434u0438u0442u0441u00a0 percutaneously in one-time dose 0.2 ml 1 time of 7 days, a course u043bu0435u0447u0435u043du0438u00a0 to 5 injections.